
LINK . SPRINGER . COM {
}
Title:
Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer | BMC Cancer
Description:
Background Signaling pathways that converge on two different transcription factor complexes, NFκB and AP-1, have been identified in estrogen receptor (ER)-positive breast cancers resistant to the antiestrogen, tamoxifen. Methods Two cell line models of tamoxifen-resistant ER-positive breast cancer, MCF7/HER2 and BT474, showing increased AP-1 and NFκB DNA-binding and transcriptional activities, were studied to compare tamoxifen effects on NFκB and AP-1 regulated reporter genes relative to tamoxifen-sensitive MCF7 cells. The model cell lines were treated with the IKK inhibitor parthenolide (PA) or the proteasome inhibitor bortezomib (PS341), alone and in combination with tamoxifen. Expression microarray data available from 54 UCSF node-negative ER-positive breast cancer cases with known clinical outcome were used to search for potential genes signifying upregulated NFκB and AP-1 transcriptional activity in association with tamoxifen resistance. The association of these genes with patient outcome was further evaluated using node-negative ER-positive breast cancer cases identified from three other published data sets (Rotterdam, n = 209; Amsterdam, n = 68; Basel, n = 108), each having different patient age and adjuvant tamoxifen treatment characteristics. Results Doses of parthenolide and bortezomib capable of sensitizing the two endocrine resistant breast cancer models to tamoxifen were capable of suppressing NFκB and AP-1 regulated gene expression in combination with tamoxifen and also increased ER recruitment of the transcriptional co-repressor, NCoR. Transcript profiles from the UCSF breast cancer cases revealed three NFκB and AP-1 upregulated genes – cyclin D1, uPA and VEGF – capable of dichotomizing node-negative ER-positive cases into early and late relapsing subsets despite adjuvant tamoxfien therapy and most prognostic for younger age cases. Across the four independent sets of node-negative ER-positive breast cancer cases (UCSF, Rotterdam, Amsterdam, Basel), high expression of all three NFκB and AP-1 upregulated genes was associated with earliest metastatic relapse. Conclusion Altogether, these findings implicate increased NFκB and AP-1 transcriptional responses with tamoxifen resistant breast cancer and early metastatic relapse, especially in younger patients. These findings also suggest that agents capable of preventing NFκB and AP-1 gene activation may prove useful in restoring the endocrine responsiveness of such high-risk ER-positive breast cancers.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't see how the site brings in money.
The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com has a secret sauce for making money, but we can't detect it yet.
Keywords {🔍}
breast, cancer, nfκb, expression, genes, gene, cells, erpositive, cases, article, google, scholar, tamoxifen, pubmed, cas, mcf, cell, mcfher, cancers, upregulated, adjuvant, activity, treatment, growth, tam, figure, age, data, reporter, therapy, levels, nodenegative, estrogen, receptor, clinical, outcome, values, years, transcriptional, prognostic, ucsf, ncor, resistance, high, significant, tamresistant, identified, relative, showed, models,
Topics {✒️}
tam-resistant er-positive/erbb2-positive models tam-sensitive er-positive/erbb2-negative models er-positive/erbb2-negative mcf7 cells er-positive/erbb2-positive subline er-positive/erbb2-positive mcf7/her2 node-negative er-positive cases er-positive/erbb2-negative mcf7 er/her2-positive breast cancer er-positive breast cancers er-positive breast cancer urokinase-type plasminogen activator phosphatidylinositol 3-kinase/akt-mediated activation open access article redox-sensitive transcription factors tamoxifen-resistant breast carcinomas b-zip transcription factors hormone-dependent breast cancers transcription factor cross-talk kaplan-meier rfs curves er-positive tumor samples minimum frozen-wet weight 54 node-negative cases cell line models er-positive mcf7 cells tam-resistant mcf7/her2 relative cut-points arbitrarily chosen 54 ucsf node-negative estrogen receptor-dependent transcription mini-complete protease inhibitors tamoxifen-resistant tumorigenic growth er-regulated gene mechanisms er dna-binding domain human breast cancer resistant breast cancer nf-kappab signaling protein a-sepharose beads firefly luminescence/renilla luminescence ncor-bound er approaching nih grants r01-ag020521 tam-sensitive mcf-7 cells ncbi/genbank geo database tam-sensitive mcf7 resulted article download pdf 3-tk-luc reporter plasmid relapsing breast cancers plasminogen activator system individual phospho-c-jun patient relapse-free survival restore er-ncor binding er-positive status
Schema {🗺️}
WebPage:
mainEntity:
headline:Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer
description:Signaling pathways that converge on two different transcription factor complexes, NFκB and AP-1, have been identified in estrogen receptor (ER)-positive breast cancers resistant to the antiestrogen, tamoxifen. Two cell line models of tamoxifen-resistant ER-positive breast cancer, MCF7/HER2 and BT474, showing increased AP-1 and NFκB DNA-binding and transcriptional activities, were studied to compare tamoxifen effects on NFκB and AP-1 regulated reporter genes relative to tamoxifen-sensitive MCF7 cells. The model cell lines were treated with the IKK inhibitor parthenolide (PA) or the proteasome inhibitor bortezomib (PS341), alone and in combination with tamoxifen. Expression microarray data available from 54 UCSF node-negative ER-positive breast cancer cases with known clinical outcome were used to search for potential genes signifying upregulated NFκB and AP-1 transcriptional activity in association with tamoxifen resistance. The association of these genes with patient outcome was further evaluated using node-negative ER-positive breast cancer cases identified from three other published data sets (Rotterdam, n = 209; Amsterdam, n = 68; Basel, n = 108), each having different patient age and adjuvant tamoxifen treatment characteristics. Doses of parthenolide and bortezomib capable of sensitizing the two endocrine resistant breast cancer models to tamoxifen were capable of suppressing NFκB and AP-1 regulated gene expression in combination with tamoxifen and also increased ER recruitment of the transcriptional co-repressor, NCoR. Transcript profiles from the UCSF breast cancer cases revealed three NFκB and AP-1 upregulated genes – cyclin D1, uPA and VEGF – capable of dichotomizing node-negative ER-positive cases into early and late relapsing subsets despite adjuvant tamoxfien therapy and most prognostic for younger age cases. Across the four independent sets of node-negative ER-positive breast cancer cases (UCSF, Rotterdam, Amsterdam, Basel), high expression of all three NFκB and AP-1 upregulated genes was associated with earliest metastatic relapse. Altogether, these findings implicate increased NFκB and AP-1 transcriptional responses with tamoxifen resistant breast cancer and early metastatic relapse, especially in younger patients. These findings also suggest that agents capable of preventing NFκB and AP-1 gene activation may prove useful in restoring the endocrine responsiveness of such high-risk ER-positive breast cancers.
datePublished:2007-04-03T00:00:00Z
dateModified:2007-04-03T00:00:00Z
pageStart:1
pageEnd:15
license:https://creativecommons.org/licenses/by/2.0
sameAs:https://doi.org/10.1186/1471-2407-7-59
keywords:
Estrogen Receptor
Tamoxifen
Bortezomib
BT474 Cell
Adjuvant Tamoxifen
Cancer Research
Oncology
Surgical Oncology
Health Promotion and Disease Prevention
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_Article_709_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_Article_709_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_Article_709_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_Article_709_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_Article_709_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_Article_709_Fig6_HTML.jpg
isPartOf:
name:BMC Cancer
issn:
1471-2407
volumeNumber:7
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Yamei Zhou
affiliation:
name:Buck Institute for Age Research
address:
name:Buck Institute for Age Research, Novato, USA
type:PostalAddress
type:Organization
type:Person
name:Christina Yau
affiliation:
name:Buck Institute for Age Research
address:
name:Buck Institute for Age Research, Novato, USA
type:PostalAddress
type:Organization
type:Person
name:Joe W Gray
affiliation:
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Karen Chew
affiliation:
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Shanaz H Dairkee
affiliation:
name:California Pacific Medical Center Research Institute
address:
name:California Pacific Medical Center Research Institute, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Dan H Moore
affiliation:
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
type:Organization
name:California Pacific Medical Center Research Institute
address:
name:California Pacific Medical Center Research Institute, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Urs Eppenberger
affiliation:
name:Stiftung Tumorbank Basel
address:
name:Stiftung Tumorbank Basel, Riehen, Switzerland
type:PostalAddress
type:Organization
type:Person
name:Serenella Eppenberger-Castori
affiliation:
name:Stiftung Tumorbank Basel
address:
name:Stiftung Tumorbank Basel, Riehen, Switzerland
type:PostalAddress
type:Organization
type:Person
name:Christopher C Benz
affiliation:
name:Buck Institute for Age Research
address:
name:Buck Institute for Age Research, Novato, USA
type:PostalAddress
type:Organization
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer
description:Signaling pathways that converge on two different transcription factor complexes, NFκB and AP-1, have been identified in estrogen receptor (ER)-positive breast cancers resistant to the antiestrogen, tamoxifen. Two cell line models of tamoxifen-resistant ER-positive breast cancer, MCF7/HER2 and BT474, showing increased AP-1 and NFκB DNA-binding and transcriptional activities, were studied to compare tamoxifen effects on NFκB and AP-1 regulated reporter genes relative to tamoxifen-sensitive MCF7 cells. The model cell lines were treated with the IKK inhibitor parthenolide (PA) or the proteasome inhibitor bortezomib (PS341), alone and in combination with tamoxifen. Expression microarray data available from 54 UCSF node-negative ER-positive breast cancer cases with known clinical outcome were used to search for potential genes signifying upregulated NFκB and AP-1 transcriptional activity in association with tamoxifen resistance. The association of these genes with patient outcome was further evaluated using node-negative ER-positive breast cancer cases identified from three other published data sets (Rotterdam, n = 209; Amsterdam, n = 68; Basel, n = 108), each having different patient age and adjuvant tamoxifen treatment characteristics. Doses of parthenolide and bortezomib capable of sensitizing the two endocrine resistant breast cancer models to tamoxifen were capable of suppressing NFκB and AP-1 regulated gene expression in combination with tamoxifen and also increased ER recruitment of the transcriptional co-repressor, NCoR. Transcript profiles from the UCSF breast cancer cases revealed three NFκB and AP-1 upregulated genes – cyclin D1, uPA and VEGF – capable of dichotomizing node-negative ER-positive cases into early and late relapsing subsets despite adjuvant tamoxfien therapy and most prognostic for younger age cases. Across the four independent sets of node-negative ER-positive breast cancer cases (UCSF, Rotterdam, Amsterdam, Basel), high expression of all three NFκB and AP-1 upregulated genes was associated with earliest metastatic relapse. Altogether, these findings implicate increased NFκB and AP-1 transcriptional responses with tamoxifen resistant breast cancer and early metastatic relapse, especially in younger patients. These findings also suggest that agents capable of preventing NFκB and AP-1 gene activation may prove useful in restoring the endocrine responsiveness of such high-risk ER-positive breast cancers.
datePublished:2007-04-03T00:00:00Z
dateModified:2007-04-03T00:00:00Z
pageStart:1
pageEnd:15
license:https://creativecommons.org/licenses/by/2.0
sameAs:https://doi.org/10.1186/1471-2407-7-59
keywords:
Estrogen Receptor
Tamoxifen
Bortezomib
BT474 Cell
Adjuvant Tamoxifen
Cancer Research
Oncology
Surgical Oncology
Health Promotion and Disease Prevention
Biomedicine
general
Medicine/Public Health
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_Article_709_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_Article_709_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_Article_709_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_Article_709_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_Article_709_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_Article_709_Fig6_HTML.jpg
isPartOf:
name:BMC Cancer
issn:
1471-2407
volumeNumber:7
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Yamei Zhou
affiliation:
name:Buck Institute for Age Research
address:
name:Buck Institute for Age Research, Novato, USA
type:PostalAddress
type:Organization
type:Person
name:Christina Yau
affiliation:
name:Buck Institute for Age Research
address:
name:Buck Institute for Age Research, Novato, USA
type:PostalAddress
type:Organization
type:Person
name:Joe W Gray
affiliation:
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Karen Chew
affiliation:
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Shanaz H Dairkee
affiliation:
name:California Pacific Medical Center Research Institute
address:
name:California Pacific Medical Center Research Institute, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Dan H Moore
affiliation:
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
type:Organization
name:California Pacific Medical Center Research Institute
address:
name:California Pacific Medical Center Research Institute, San Francisco, USA
type:PostalAddress
type:Organization
type:Person
name:Urs Eppenberger
affiliation:
name:Stiftung Tumorbank Basel
address:
name:Stiftung Tumorbank Basel, Riehen, Switzerland
type:PostalAddress
type:Organization
type:Person
name:Serenella Eppenberger-Castori
affiliation:
name:Stiftung Tumorbank Basel
address:
name:Stiftung Tumorbank Basel, Riehen, Switzerland
type:PostalAddress
type:Organization
type:Person
name:Christopher C Benz
affiliation:
name:Buck Institute for Age Research
address:
name:Buck Institute for Age Research, Novato, USA
type:PostalAddress
type:Organization
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:BMC Cancer
issn:
1471-2407
volumeNumber:7
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Buck Institute for Age Research
address:
name:Buck Institute for Age Research, Novato, USA
type:PostalAddress
name:Buck Institute for Age Research
address:
name:Buck Institute for Age Research, Novato, USA
type:PostalAddress
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
name:California Pacific Medical Center Research Institute
address:
name:California Pacific Medical Center Research Institute, San Francisco, USA
type:PostalAddress
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
name:California Pacific Medical Center Research Institute
address:
name:California Pacific Medical Center Research Institute, San Francisco, USA
type:PostalAddress
name:Stiftung Tumorbank Basel
address:
name:Stiftung Tumorbank Basel, Riehen, Switzerland
type:PostalAddress
name:Stiftung Tumorbank Basel
address:
name:Stiftung Tumorbank Basel, Riehen, Switzerland
type:PostalAddress
name:Buck Institute for Age Research
address:
name:Buck Institute for Age Research, Novato, USA
type:PostalAddress
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Yamei Zhou
affiliation:
name:Buck Institute for Age Research
address:
name:Buck Institute for Age Research, Novato, USA
type:PostalAddress
type:Organization
name:Christina Yau
affiliation:
name:Buck Institute for Age Research
address:
name:Buck Institute for Age Research, Novato, USA
type:PostalAddress
type:Organization
name:Joe W Gray
affiliation:
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
type:Organization
name:Karen Chew
affiliation:
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
type:Organization
name:Shanaz H Dairkee
affiliation:
name:California Pacific Medical Center Research Institute
address:
name:California Pacific Medical Center Research Institute, San Francisco, USA
type:PostalAddress
type:Organization
name:Dan H Moore
affiliation:
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
type:Organization
name:California Pacific Medical Center Research Institute
address:
name:California Pacific Medical Center Research Institute, San Francisco, USA
type:PostalAddress
type:Organization
name:Urs Eppenberger
affiliation:
name:Stiftung Tumorbank Basel
address:
name:Stiftung Tumorbank Basel, Riehen, Switzerland
type:PostalAddress
type:Organization
name:Serenella Eppenberger-Castori
affiliation:
name:Stiftung Tumorbank Basel
address:
name:Stiftung Tumorbank Basel, Riehen, Switzerland
type:PostalAddress
type:Organization
name:Christopher C Benz
affiliation:
name:Buck Institute for Age Research
address:
name:Buck Institute for Age Research, Novato, USA
type:PostalAddress
type:Organization
name:University of California
address:
name:Comprehensive Cancer Center, University of California, San Francisco, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Buck Institute for Age Research, Novato, USA
name:Buck Institute for Age Research, Novato, USA
name:Comprehensive Cancer Center, University of California, San Francisco, USA
name:Comprehensive Cancer Center, University of California, San Francisco, USA
name:California Pacific Medical Center Research Institute, San Francisco, USA
name:Comprehensive Cancer Center, University of California, San Francisco, USA
name:California Pacific Medical Center Research Institute, San Francisco, USA
name:Stiftung Tumorbank Basel, Riehen, Switzerland
name:Stiftung Tumorbank Basel, Riehen, Switzerland
name:Buck Institute for Age Research, Novato, USA
name:Comprehensive Cancer Center, University of California, San Francisco, USA
External Links {🔗}(177)
- Profit of https://www.springernature.com/gp/authors
- What's the profit of https://link.springernature.com/home/?
- How much does https://order.springer.com/public/cart gross monthly?
- What's the monthly income of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- Get to know https://bmccancer.biomedcentral.com/about's earnings
- How much does https://submission.nature.com/new-submission/12885/3 rake in every month?
- How much does https://doi.org/10.1210%2Fme.2003-0044 pull in monthly?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15031323?
- How much does http://scholar.google.com/scholar_lookup?&title=Genomic%20targets%20of%20nuclear%20estrogen%20receptors&journal=Mol%20Endocrinol&doi=10.1210%2Fme.2003-0044&volume=18&pages=1859-1875&publication_year=2004&author=O%27Lone%2CR&author=Frith%2CMC&author=Karlsson%2CEK&author=Hansen%2CU make?
- How much revenue does https://doi.org/10.1016%2Fj.mce.2005.10.003 generate?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16298037
- How much profit does http://scholar.google.com/scholar_lookup?&title=ERE-independent%20ER%CE%B1%20target%20genes%20differentially%20expressed%20in%20human%20breast%20tumors&journal=Mol%20Cell%20Endocrinol&doi=10.1016%2Fj.mce.2005.10.003&volume=245&pages=53-59&publication_year=2005&author=Glidewell-Kenney%2CC&author=Weiss%2CJ&author=Lee%2CE-J&author=Pillai%2CS&author=Ishikawa%2CT&author=Ariazi%2CEA&author=Jameson%2CJL generate?
- How much does https://doi.org/10.1677%2Ferc.0.0050271 make?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Transcription%20factors%20and%20breast%20cancer&journal=Endocrine-Related%20Cancer&doi=10.1677%2Ferc.0.0050271&volume=5&pages=271-282&publication_year=1998&author=Benz%2CCC?
- Earnings of https://doi.org/10.1677%2Ferc.0.0100517
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14713265
- How much income is http://scholar.google.com/scholar_lookup?&title=Estrogen%20receptor%20corepressors--a%20role%20in%20human%20breast%20cancer&journal=Endocrine-Related%20Cancer&doi=10.1677%2Ferc.0.0100517&volume=10&pages=517-536&publication_year=2003&author=Dobrzycka%2CKM&author=Townson%2CSM&author=Jiang%2CS&author=Oesterreich%2CS earning monthly?
- How much revenue does https://doi.org/10.1016%2Fj.cell.2006.04.021 produce monthly?
- Earnings of http://scholar.google.com/scholar_lookup?&title=The%20expanding%20cosmos%20of%20nuclear%20receptor%20coactivators&journal=Cell&doi=10.1016%2Fj.cell.2006.04.021&volume=125&pages=411-414&publication_year=2003&author=Lonard%2CDM&author=O%27Malley%2CBW
- How much does https://doi.org/10.1210%2Fme.2004-0395 net monthly?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15802375?
- How much does http://scholar.google.com/scholar_lookup?&title=Cell%20cycle%20progression%20stimulated%20by%20tamoxifen-bound%20estrogen%20receptor%20%CE%B1%20and%20promoter-specific%20effects%20in%20breast%20cancer%20cells%20deficient%20in%20NCoR%20and%20SMRT&journal=Mol%20Endocrinol&doi=10.1210%2Fme.2004-0395&volume=19&pages=1543-1554&publication_year=2005&author=Keeton%2CEK&author=Brown%2CM pull in monthly?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12684393 have?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Expression%20analysis%20of%20estrogen%20receptor%20%CE%B1%20coregulators%20in%20breast%20carcinoma%3A%20evidence%20that%20NCOR1%20expression%20is%20predictive%20of%20the%20response%20to%20tamoxifen&journal=Clin%20Cancer%20Res&volume=9&pages=1259-1266&publication_year=2003&author=Girault%2CI&author=Lerebours%2CF&author=Amarir%2CS&author=Tozlu%2CS&author=Tubiana-Hulin%2CM&author=Lidereau%2CR&author=Bieche%2CI earns monthly
- Get to know https://doi.org/10.1016%2Fj.ccr.2006.09.015's earnings
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17157789's gross income?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Disruption%20of%20estrogen%20receptor%20DNA-binding%20domain%20and%20related%20intramolecular%20communication%20restores%20tamoxifen%20sensitivity%20in%20resistant%20breast%20cancer&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2006.09.015&volume=10&pages=487-499&publication_year=2006&author=Wang%2CLH&author=Yang%2CXY&author=Zhang%2CZ&author=Ping%2CA&author=Kim%2CH-J&author=Huang%2CJ&author=Clarke%2CR&author=Osborne%2CCK&author=Inman%2CJK&author=Appella%2CE&author=Farrar%2CWL
- How much cash flow does https://doi.org/10.1016%2Fj.tem.2005.01.004 have monthly?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15734144
- http://scholar.google.com/scholar_lookup?&title=Transcription%20factor%20cross-talk%3A%20the%20estrogen%20receptor%20and%20NF-kappaB&journal=Trends%20Endocrinol%20Metab&doi=10.1016%2Fj.tem.2005.01.004&volume=16&pages=46-52&publication_year=2005&author=Kalaitzidis%2CD&author=Gilmore%2CTD income
- How much profit is http://scholar.google.com/scholar_lookup?&title=Crossroads%20of%20estrogen%20receptor%20and%20NF-kappaB%20signaling&journal=Sci%20STKE&doi=10.1126%2Fstke.2882005pe27&volume=288&publication_year=2005&author=Biswas%2CDK&author=Singh%2CS&author=Shi%2CQ&author=Pardee%2CAB&author=Iglehart%2CJD making per month?
- Income figures for https://doi.org/10.1677%2Ferc.1.00977
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16113098?
- How much money does http://scholar.google.com/scholar_lookup?&title=The%20NF%CE%BAB%20pathway%20and%20endocrine%20resistant%20breast%20cancer&journal=Endocrine-Related%20Cancer&doi=10.1677%2Ferc.1.00977&volume=12&issue=Suppl%201&pages=S37-S46&publication_year=2005&author=Zhou%2CY&author=Eppenberger-Castori%2CS&author=Eppenberger%2CU&author=Benz%2CCC generate?
- What's the total monthly financial gain of https://doi.org/10.1210%2Fmend.13.10.0357?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10517669?
- http://scholar.google.com/scholar_lookup?&title=The%20estrogen%20receptor%20enhances%20AP-1%20activity%20by%20two%20distinct%20mechanisms%20with%20different%20requirements%20for%20receptor%20transactivation%20functions&journal=Mol%20Endocrinol&doi=10.1210%2Fme.13.10.1672&volume=13&pages=1672-1685&publication_year=1999&author=Webb%2CP&author=Nguyen%2CP&author=Valentine%2CC&author=Lopez%2CGN&author=Kwok%2CGR&author=McInerney%2CE&author=Katzenellenbogen%2CBS&author=Enmark%2CE&author=Gustafsson%2CJA&author=Nilsson%2CS&author=Kushner%2CPJ's total income per month
- What's the income of https://doi.org/10.1016%2FS0960-0760%2800%2900108-4?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11162939 generate monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Estrogen%20receptor%20pathways%20to%20AP-1&journal=J%20Steroid%20Biochem%20Mol%20Biol&doi=10.1016%2FS0960-0760%2800%2900108-4&volume=74&pages=311-317&publication_year=2000&author=Kushner%2CPJ&author=Agard%2CDA&author=Green%2CGL&author=Scanlan%2CTS&author=Shiau%2CAK&author=Uht%2CRM&author=Webb%2CP produce monthly?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11278408?
- http://scholar.google.com/scholar_lookup?&title=Estrogen%20receptor%20binding%20to%20DNA%20is%20not%20required%20for%20its%20activity%20through%20the%20nonclassical%20AP1%20pathway&journal=J%20Biol%20Chem&volume=276&pages=13615-13621&publication_year=2001&author=Jakacka%2CM&author=Ito%2CM&author=Weiss%2CJ&author=Chien%2CPY&author=Gehm%2CBD&author=Jameson%2CJL's revenue stream
- Explore the financials of https://doi.org/10.1073%2Fpnas.0407113102
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Altered%20pharmacology%20and%20distinct%20coactivator%20usage%20for%20estrogen%20receptor-dependent%20transcription%20through%20activating%20protein-1.%20Proc&journal=Natl%20Acad%20Sci%20%28USA%29&doi=10.1073%2Fpnas.0407113102&volume=102&pages=559-564&publication_year=2005&author=Cheung%2CE&author=Acevedo%2CML&author=Cole%2CPA&author=Kraus%2CWL
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8838865?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Progression%20of%20MCF-7%20breast%20cancer%20cells%20to%20antiestrogen-resistant%20phenotype%20is%20accompanied%20by%20elevated%20levels%20of%20AP-1%20DNA-binding%20activity&journal=Cell%20Growth%20and%20Differentiation&volume=7&pages=351-359&publication_year=1996&author=Dumont%2CJP&author=Bitoni%2CAJ&author=Wallace%2CCD&author=Baumann%2CRJ&author=Cashman%2CEA&author=Cross-Doersen%2CDE
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10037172?
- Get to know http://scholar.google.com/scholar_lookup?&title=Increased%20activator%20protein-1%20DNA%20binding%20and%20c-Jun%20NH2-terminal%20kinase%20activity%20in%20human%20breast%20tumors%20with%20acquired%20tamoxifen%20resistance&journal=Clin%20Cancer%20Res&volume=5&pages=251-6&publication_year=1999&author=Johnston%2CSR&author=Lu%2CB&author=Scott%2CGK&author=Kushner%2CPJ&author=Smith%2CIE&author=Dowsett%2CM&author=Benz%2CCC's earnings
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8095168
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Estrogen-dependent%2C%20tamoxifen-resistant%20tumorigenic%20growth%20of%20MCF-7%20cells%20transfected%20with%20HER2%2Fneu&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2FBF01961241&volume=24&pages=85-95&publication_year=1992&author=Benz%2CCC&author=Scott%2CGK&author=Sarup%2CJC&author=Johnson%2CRM&author=Tripathy%2CD&author=Coronado%2CE&author=Shepard%2CHM&author=Osborne%2CCK
- What's the financial intake of https://doi.org/10.1016%2Fj.biocel.2004.09.006?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15743683's total income per month
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Activation%20of%20nuclear%20factor-%CE%BAB%20%28NF%CE%BAB%29%20identifies%20a%20high-risk%20subset%20of%20hormone-dependent%20breast%20cancers&journal=Int%20J%20Biochem%20Cell%20Biol&doi=10.1016%2Fj.biocel.2004.09.006&volume=37&pages=1130-1144&publication_year=2005&author=Zhou%2CY&author=Eppenberger-Castori%2CS&author=Marx%2CC&author=Yau%2CC&author=Scott%2CGK&author=Eppenberger%2CU&author=Benz%2CCC?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Age-associated%20differences%20in%20primary%20breast%20cancer%20gene%20expression%20profiles&journal=Proc&volume=47&publication_year=2006&author=Yau%2CC&author=Fedele%2CV&author=Hubbard%2CA&author=Moore%2CD&author=Chew%2CK&author=Dairkee%2CS&author=Tommasi%2CS&author=Paradiso%2CA&author=Gray%2CJ&author=Albertson%2CD&author=Benz%2CCC
- What's the income generated by https://doi.org/10.1038%2F415530a each month?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Gene%20expression%20profiling%20predicts%20clinical%20outcome%20of%20breast%20cancer&journal=Nature&doi=10.1038%2F415530a&volume=415&pages=530-536&publication_year=2002&author=Van%27t%20Veer%2CLJ&author=Dai%2CH&author=van%20de%20Vijver%2CMJ&author=He%2CYD&author=Hart%2CAA&author=Mao%2CM&author=Peterse%2CHS&author=van%20der%20Kooy%2CK&author=Marton%2CMJ&author=Witteveen%2CAT&author=Schreiber%2CGJ&author=Kerkhoven%2CRM&author=Roberts%2CC&author=Linsley%2CPS&author=Bernards%2CR&author=Friend%2CSH?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11213252's total income per month
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=The%20plasminogen%20activator%20system%3A%20biology%20and%20regulation&journal=Cell%20Mol%20Life%20Sci&doi=10.1007%2FPL00000615&volume=56&pages=104-132&publication_year=1999&author=Irigoyen%2CJP&author=Munoz-Canoves%2CP&author=Montero%2CL&author=Koziczak%2CM&author=Nagamine%2CY?
- How much revenue does https://doi.org/10.1006%2Fbbrc.2001.6225 bring in?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11779207's gross income?
- How much income is http://scholar.google.com/scholar_lookup?&title=Protein%20kinase%20C%20induces%20motility%20of%20breast%20cancers%20by%20upregulating%20secretion%20of%20urokinase-type%20plasminogen%20activator%20through%20activation%20of%20AP-1%20and%20NF-%CE%BAB&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1006%2Fbbrc.2001.6225&volume=290&pages=552-557&publication_year=2002&author=Sliva%2CD&author=English%2CD&author=Lyons%2CD&author=Lloyd%20FP%2CJr earning monthly?
- See how much https://doi.org/10.1128%2FMCB.24.17.7806-7819.2004 makes per month
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15314185
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC507000 produce monthly?
- Find out how much http://scholar.google.com/scholar_lookup?&title=NF%CE%BAB%20and%20AP-1%20connection%3A%20mechanism%20of%20NF%CE%BAB%20dependent%20regulation%20of%20AP-1%20activity&journal=Mol%20Cell%20Biol&doi=10.1128%2FMCB.24.17.7806-7819.2004&volume=24&pages=7806-7819&publication_year=2004&author=Fujioka%2CS&author=Niu%2CJ&author=Schmidt%2CC&author=Sclabas%2CGM&author=Peng%2CB&author=Uwagawa%2CT&author=Li%2CZ&author=Evans%2CDB&author=Abbruzzese%2CJL&author=Chiao%2CPJ earns monthly
- How much income does https://doi.org/10.1677%2Fjme.1.01599 have?
- How much money does http://scholar.google.com/scholar_lookup?&title=Differential%20effects%20of%2016a-hydroxyestrone%20and%202-methoxyestradiol%20on%20cyclin%20D1%20involving%20the%20transcription%20factor%20ATF-2%20in%20MCF7%20breast%20cancer%20cells&journal=J%20Mol%20Endo&doi=10.1677%2Fjme.1.01599&volume=34&pages=91-105&publication_year=2005&author=Lewis%2CJA&author=Thomas%2CTJ&author=Pestell%2CRG&author=Albanese%2CC&author=Gallo%2CMA&author=Thomas%2CT make?
- What's the financial intake of https://doi.org/10.1016%2Fj.lfs.2005.07.042?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16253280
- Get to know http://scholar.google.com/scholar_lookup?&title=Different%20effects%20of%20estradiol%20and%20various%20antiestrogens%20on%20TNF-alpha-induced%20changes%20of%20biochemical%20markers%20for%20growth%20and%20invasion%20of%20human%20breast%20cancer%20cells&journal=Life%20Sci&doi=10.1016%2Fj.lfs.2005.07.042&volume=78&pages=1464-1468&publication_year=2006&author=Seeger%2CH&author=Wallwiener%2CD&author=Mueck%2CAO's earnings
- Financial intake of https://doi.org/10.1016%2FS0140-6736%2805%2970933-8
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15721472 produce monthly?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Gene%20expression%20profiles%20to%20predict%20distant%20metastasis%20of%20lymph%20node-negative%20primary%20breast%20cancer&journal=Lancet&doi=10.1016%2FS0140-6736%2805%2970933-8&volume=365&pages=671-679&publication_year=2005&author=Wang%2CY&author=KIijn%2CJG&author=Zhang%2CY&author=Sieuwerts%2CAM&author=Look%2CMP&author=Yang%2CF&author=Talantov%2CD&author=Timmermans%2CM&author=Meijer-van%20Gelder%2CME&author=Yu%2CJ&author=Jatkoe%2CT&author=Berns%2CEM&author=Atkins%2CD&author=Foekens%2CJA
- What's the monthly money flow for https://doi.org/10.1200%2FJCO.2005.05.1912?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16963728?
- What's http://scholar.google.com/scholar_lookup?&title=Increased%20expression%20of%20urokinase-type%20plasminogen%20activator%20mRNA%20determines%20adverse%20prognosis%20in%20ErbB2-positive%20primary%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.05.1912&volume=24&pages=4245-4253&publication_year=2006&author=Urban%2CP&author=Vuaroqueaux%2CV&author=Labuhn%2CM&author=Delorenzi%2CM&author=Wirapati%2CP&author=Wight%2CE&author=Senn%2CH-J&author=Benz%2CC&author=Eppenberger%2CU&author=Eppenberger-Castori%2CS's gross income?
- How much income does https://doi.org/10.1038%2Fsj.onc.1203412 have?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10713699?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Selective%20activation%20of%20NF-%CE%BAB%20subunits%20in%20human%20breast%20cancer%3A%20potential%20roles%20for%20p52%20and%20for%20Bcl-3&journal=Oncogene&doi=10.1038%2Fsj.onc.1203412&volume=19&pages=1123-1131&publication_year=2000&author=Cogswell%2CPC&author=Gutteridge%2CDC&author=Funkhouser%2CWK&author=Baldwin%2CAS?
- How much money does https://doi.org/10.1016%2FS0092-8674%2802%2900703-1 make?
- Get to know http://scholar.google.com/scholar_lookup?&title=Missing%20pieces%20in%20the%20NF-%CE%BAB%20puzzle&journal=Cell&doi=10.1016%2FS0092-8674%2802%2900703-1&volume=109&pages=81s-96s&publication_year=2002&author=Ghosh%2CS&author=Karin%2CM's earnings
- See how much https://doi.org/10.1128%2FMCB.23.19.6887-6900.2003 makes per month
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12972607's earnings
- Explore the financials of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC193930
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Estrogen%20withdrawal-induced%20NF-kappaB%20activity%20and%20bcl-3%20expression%20in%20breast%20cancer%20cells%3A%20roles%20in%20growth%20and%20hormone%20independence&journal=Mol%20Cell%20Biol&doi=10.1128%2FMCB.23.19.6887-6900.2003&volume=23&pages=6887-900&publication_year=2003&author=Pratt%2CMA&author=Bishop%2CTE&author=White%2CD&author=Yasvinski%2CG&author=Menard%2CM&author=Niu%2CMY&author=Clarke%2CR
- How much does http://scholar.google.com/scholar_lookup?&title=ErbB2%2FHER2%20and%20other%20molecular%20pathways%20in%20ER-positive%20breast%20cancer%3A%20impact%20on%20endocrine%20resistance%20and%20clinical%20outcome&publication_year=2004&author=Benz%2CCC pull in monthly?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-04-2569 pull in monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=A%20meta-analysis%20on%20the%20interaction%20between%20HER-2%20expression%20and%20response%20to%20endocrine%20treatment%20in%20advanced%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-2569&volume=11&pages=4741-4748&publication_year=2005&author=DeLaurentiis%2CM&author=Arpino%2CG&author=Massarelli%2CE&author=Ruggiero%2CA&author=Carlomagno%2CC&author=Ciardiello%2CF&author=Tortora%2CG&author=D%27Agostino%2CD&author=Caputo%2CF&author=Cancello%2CG&author=Montagna%2CE&author=Malorni%2CL&author=Zinno%2CL&author=Lauria%2CR&author=Bianco%2CAR&author=De%20Placido%2CS earning monthly?
- Revenue of https://doi.org/10.1073%2Fpnas.191367098
- What's the income of http://scholar.google.com/scholar_lookup?&title=Gene%20expression%20patterns%20of%20breast%20carcinomas%20distinguish%20tumor%20subclasses%20with%20clinical%20implications&journal=Proc%20Natl%20Acad%20Sci%20%28USA%29&doi=10.1073%2Fpnas.191367098&volume=98&pages=10869-10874&publication_year=2001&author=Sorlie%2CT&author=Perou%2CCM&author=Tibshirani%2CR&author=Aas%2CT&author=Geisler%2CS&author=Johnson%2CH&author=Hastie%2CT&author=Eisen%2CMB&author=van%20de%20Rijn%2CM&author=Jeffrey%2CSS&author=Thorsen%2CT&author=Quist%2CH&author=Matese%2CJC&author=Brown%2CPO&author=Botstein%2CD&author=Lonning%2CPE&author=Borresen-Dale%2CA-L?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11507038
- How much income does http://scholar.google.com/scholar_lookup?&title=Estrogen%20receptor%20status%20in%20breast%20cancer%20is%20associated%20with%20remarkably%20distinct%20gene%20expression%20patterns&journal=Cancer%20Res&volume=61&pages=5979-5984&publication_year=2001&author=Gruvberger%2CS&author=Ringner%2CM&author=Chen%2CY&author=Panavally%2CS&author=Saal%2CLH&author=Borg%2CA&author=Ferno%2CM&author=Peterson%2CC&author=Meltzer%2CPS have?
- Learn how profitable https://doi.org/10.1200%2FJCO.2005.05.145 is on a monthly basis
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15681518?
- How much income does http://scholar.google.com/scholar_lookup?&title=Molecular%20classification%20of%20tamoxifen-resistant%20breast%20carcinomas%20by%20gene%20expression%20profiling&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2005.05.145&volume=23&pages=732-740&publication_year=2005&author=Jansen%2CMPHM&author=Foekens%2CJA&author=vanStaveren%2CIL&author=Dirkzwager-Kiel%2CMM&author=Ritstier%2CK&author=Look%2CMP&author=Meijer-van%20Gelder%2CME&author=Sieuwerts%2CAM&author=Portengen%2CH&author=Dorssers%2CLCJ&author=Klijn%2CJGM&author=Berns%2CEMJJ have?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12538508 bring in?
- How much profit does http://scholar.google.com/scholar_lookup?&title=ErbB%20%28HER%29%20receptors%20can%20abrogate%20antiestrogen%20action%20in%20human%20breast%20cancer%20by%20multiple%20signaling%20mechanisms&journal=Clin%20Cancer%20Res&volume=9&pages=511s-5155s&publication_year=2003&author=Kurokawa%2CH&author=Arteaga%2CCL generate?
- Discover the revenue of https://doi.org/10.1158%2F1078-0432.CCR-031212
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14734488
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Cross-talk%20between%20estrogen%20receptor%20and%20growth%20factor%20pathways%20as%20a%20molecular%20target%20for%20overcoming%20endocrine%20resistance&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-031212&volume=10&pages=331s-336s&publication_year=2004&author=Schiff%2CR&author=Massarweh%2CSA&author=Shou%2CJ&author=Bharwani%2CL&author=Mohsin%2CIK&author=Osborne%2CCK
- How much income does https://doi.org/10.1093%2Fjnci%2Fdjh166 have?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15199112 generate?
- http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20tamoxifen%20resistance%3A%20increased%20estrogen%20receptor-HER2%2Fneu%20cross-talk%20in%20ER%2FHER2-positive%20breast%20cancer&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjh166&volume=96&pages=926-935&publication_year=2004&author=Shou%2CJ&author=Massarweh%2CS&author=Osborne%2CCK&author=Wakeling%2CAE&author=%C3%85li%2CS&author=Weiss%2CH&author=Schiff%2CR income
- What's the financial gain of https://doi.org/10.1158%2F1078-0432.CCR-05-2268?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16467115?
- How much does http://scholar.google.com/scholar_lookup?&title=Proceedings%20of%20the%20fifth%20international%20conference%20on%20recent%20advances%20and%20future%20directions%20in%20endocrine%20therapy%20for%20breast%20cancer%3A%20conference%20summary%20statement&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-2268&volume=12&issue=Suppl%203&pages=997s-1000s&publication_year=2006&author=Come%2CSE&author=Buzdar%2CAU&author=Ingle%2CJN&author=Arteaga%2CCL&author=Brown%2CM&author=Dowsett%2CM&author=Hilsenbeck%2CSG&author=Kumar%2CR&author=Johnston%2CSRD&author=Lee%2CAV&author=Paik%2CS&author=Pritchard%2CKI&author=Winer%2CEP&author=Hart%2CC net monthly?
- https://doi.org/10.1038%2Fsj.bjc.6690112's total income per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10070856 make?
- What's http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362670's gross income?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Altered%20expression%20of%20the%20IGF-1%20receptor%20in%20a%20tamoxifen-resistant%20human%20breast%20cancer%20cell%20line&journal=Br%20J%20Cancer&doi=10.1038%2Fsj.bjc.6690112&volume=79&pages=693-700&publication_year=1999&author=Parisot%2CJP&author=Hu%2CXF&author=DeLuise%2CM&author=Zalcberg%2CJR is on a monthly basis
- What are the earnings of https://doi.org/10.1074%2Fjbc.M010840200?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11139588's total income per month
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Phosphatidylinositol%203-kinase%2FAKT-mediated%20activation%20of%20estrogen%20receptor%20alphas%3A%20a%20new%20model%20for%20anti-estrogen%20resistance&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M010840200&volume=276&pages=9817-24&publication_year=2001&author=Campbell%2CRA&author=Bhat-Nakshatri%2CP&author=Patel%2CNM&author=Constantinidou%2CD&author=Ali%2CS&author=Nakshatri%2CH?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11595710 make?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Novel%20antitumor%20effect%20of%20estradiol%20in%20athymic%20mice%20injected%20with%20a%20T47D%20breast%20cancer%20cell%20line%20overexpressing%20protein%20kinase%20Calpha&journal=Clin%20Cancer%20Res&volume=7&pages=3156-65&publication_year=2001&author=Chisamore%2CMJ&author=Ahmed%2CY&author=Bentrem%2CDJ&author=Jordan%2CVC&author=Tonetti%2CDA?
- How much does https://doi.org/10.1677%2Ferc.1.01054 gross monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16113086's total income per month
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Consensus%20statement.%20Workshop%20on%20therapeutic%20resistance%20in%20breast%20cancer%3A%20impact%20of%20growth%20factor%20signaling%20pathways%20and%20implications%20for%20future%20treatment&journal=Endocrine-Related%20Cancer&doi=10.1677%2Ferc.1.01054&volume=12&issue=Suppl%201&pages=S1-7&publication_year=2005&author=Gee%2CJM&author=Howell%2CA&author=Gullick%2CWJ&author=Benz%2CCC&author=Sutherland%2CRL&author=Santen%2CRJ&author=Martin%2CLA&author=Ciardiello%2CF&author=Miller%2CWR&author=Dowsett%2CM&author=Barrett-Lee%2CP&author=Robertson%2CJF&author=Johnston%2CSR&author=Jones%2CHE&author=Wakeling%2CAE&author=Duncan%2CR&author=Nicholson%2CRI produce monthly?
- How much does https://doi.org/10.1158%2F1078-0432.CCR-05-2125 pull in?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16467125 make?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Clinical%20efforts%20to%20combine%20endocrine%20agents%20with%20targeted%20therapies%20against%20epidermal%20growth%20factor%20receptor%2Fhuman%20epidermal%20growth%20factor%20receptor%202%20and%20mammalian%20target%20of%20rapamycin%20in%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-2125&volume=12&issue=Suppl%203&pages=1061s-1068s&publication_year=2006&author=Johnston%2CSRD
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11059787 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20HER2%2Fneu%20%28erbB2%29%20and%20mitogen-activated%20protein%20kinases%20enhances%20tamoxifen%20action%20against%20HER2-overexpressing%2C%20tamoxifen-resistant%20breast%20cancer%20cells&journal=Cancer%20Res&volume=60&pages=5887-5894&publication_year=2000&author=Kurokawa%2CH&author=Lenferink%2CAEG&author=Simpson%2CJF&author=Pisacane%2CPI&author=Sliwkowski%2CMX&author=Forbes%2CJT&author=Arteaga%2CCL pull in?
- Check the income stats for https://doi.org/10.1158%2F0008-5472.CAN-03-3848
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15231667
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Urokinase-type%20plasminogen%20activator%20system%20in%20breast%20cancer%3A%20association%20with%20tamoxifen%20therapy%20in%20recurrent%20disease&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-03-3848&volume=64&pages=4563-4568&publication_year=2004&author=Meijer-van%20Gelder%2CME&author=Look%2CMP&author=Peters%2CHA&author=Schmitt%2CM&author=Brunner%2CN&author=Harbeck%2CN&author=Klijn%2CJGM&author=Foekens%2CJA
- How much revenue does https://doi.org/10.1677%2Ferc.1.00993 bring in?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16113099
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Downstream%20targets%20of%20growth%20factor%20and%20oestrogen%20signaling%20and%20endocrine%20resistance%3A%20the%20potential%20roles%20of%20c-Myc%2C%20cyclin%20D1%20and%20cyclin%20E&journal=Endocrine-Related%20Cancer&doi=10.1677%2Ferc.1.00993&volume=12&pages=S47-S59&publication_year=2005&author=Butt%2CAJ&author=McNeil%2CCM&author=Musgrove%2CEA&author=Sutherland%2CRL
- How much does https://doi.org/10.1158%2F1078-0432.CCR-05-2296 pull in?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16467119 income
- http://scholar.google.com/scholar_lookup?&title=Methods%20for%20gene%20expression%20profiling%20in%20clinical%20trials%20of%20adjuvant%20breast%20cancer%20therapy&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-2296&volume=12&issue=Suppl%203&pages=1019s-1023s&publication_year=2006&author=Paik%2CS's total income per month
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Redox-sensitive%20transcription%20factors%20as%20prime%20targets%20for%20chemoprevention%20with%20anti-inflammatory%20and%20antioxidative%20phytochemicals&journal=J%20Nutr&volume=135&pages=29993S-3001S&publication_year=2005&author=Surh%2CY-J&author=Kundu%2CJK&author=Na%2CH-K&author=Lee%2CJ-S?
- How much does http://www.biomedcentral.com/1471-2407/7/59/prepub pull in?
- How much income does https://citation-needed.springer.com/v2/references/10.1186/1471-2407-7-59?format=refman&flavour=references have?
- What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yamei%20Zhou?
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yamei%20Zhou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christina%20Yau's total income per month
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christina%20Yau%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Joe%20W%20Gray
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Joe%20W%20Gray%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Karen%20Chew?
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Karen%20Chew%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shanaz%20H%20Dairkee
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shanaz%20H%20Dairkee%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dan%20H%20Moore have?
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dan%20H%20Moore%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Urs%20Eppenberger
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Urs%20Eppenberger%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Serenella%20Eppenberger-Castori
- What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Serenella%20Eppenberger-Castori%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christopher%20C%20Benz?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christopher%20C%20Benz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_709_MOESM1_ESM.pdf pull in monthly?
- How much cash flow does https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_709_MOESM2_ESM.pdf have monthly?
- Monthly income for https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_709_MOESM3_ESM.pdf
- What's the revenue for https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_709_MOESM4_ESM.pdf?
- https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_709_MOESM5_ESM.pdf's total income per month
- How much does https://static-content.springer.com/esm/art%3A10.1186%2F1471-2407-7-59/MediaObjects/12885_2006_709_MOESM6_ESM.pdf net monthly?
- Learn about the earnings of https://creativecommons.org/licenses/by/2.0
- How much does https://s100.copyright.com/AppDispatchServlet?title=Enhanced%20NF%CE%BAB%20and%20AP-1%20transcriptional%20activity%20associated%20with%20antiestrogen%20resistant%20breast%20cancer&author=Yamei%20Zhou%20et%20al&contentID=10.1186%2F1471-2407-7-59©right=Zhou%20et%20al%3B%20licensee%20BioMed%20Central%20Ltd.&publication=1471-2407&publicationDate=2007-04-03&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY net monthly?
- Learn how profitable https://citation-needed.springer.com/v2/references/10.1186/1471-2407-7-59?format=refman&flavour=citation is on a monthly basis
- https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral income
- How much income does https://www.springernature.com/gp/products have?
- How much does https://www.springernature.com/gp/librarians pull in monthly?
- Income figures for https://www.springernature.com/gp/societies
- Earnings of https://www.springernature.com/gp/partners
- What's the income generated by https://www.springer.com/ each month?
- How much does https://www.nature.com/ bring in each month?
- How much does https://www.biomedcentral.com/ gross monthly?
- How much revenue does https://www.palgrave.com/ produce monthly?
- How much income is https://www.apress.com/ earning monthly?
- Get to know what's the income of https://www.springernature.com/gp/legal/ccpa
- What's the profit of https://www.springernature.com/gp/info/accessibility?
- How much does https://support.springernature.com/en/support/home pull in?
- What's the financial gain of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- Earnings of https://www.springernature.com/
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref